Phase II trial of recombinant alpha-2b-Interferon and low-dose cyclophosphamide in advanced melanoma and renal cell carcinoma

S. Wadler, A. I. Einzig, J. P. Dutcher, N. Ciobanu, L. Landau, P. H. Wiernik

Research output: Contribution to journalArticlepeer-review

23 Scopus citations

Fingerprint Dive into the research topics of 'Phase II trial of recombinant alpha-2b-Interferon and low-dose cyclophosphamide in advanced melanoma and renal cell carcinoma'. Together they form a unique fingerprint.

Medicine & Life Sciences